IRD

Opus GeneticsF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-03

View Chart

AI scenario view

RankAlpha Sentiment AI

B+

Bull case

20%

Probability

Target price

$2.91

-30.7% vs current

Most likely

Base case

60%

Probability

Target price

$1.82

-56.7% vs current

B-

Bear case

20%

Probability

Target price

$0.91

-78.3% vs current

AI sentiment snapshot

Latest data as of 2025-09-29

AI commentary

Market sentiment appears cautious-to-neutral with emphasis on near-term financing and clinical/data catalysts; press and market threads highlight liquidity concerns alongside optimism for platform potential [#yfinance]. Recent coverage and chatter focus on fundraising and partnership expectations rather than broad institutional conviction [#news].

RankAlpha Sentiment AI - 2025-09-29

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

No AI events listed.

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2025-09-29 • Updated nightlySource: Internal modelMethodology